MedTrace Logo

Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese Patients

NCT04863053 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 266

Last updated 2021-04-28

No results posted yet for this study

Summary

The hypotheses of the study are that the diagnostic accuracy of Multiplate® device for diagnosis of aspirin resistance is comparable to the serum TXB2 assay and that certain genetic polymorphisms and phenotypic factors significantly influence the antiplatelet effect of aspirin and contribute to aspirin resistance observed in this study.

Conditions

  • Coronary Disease

Interventions

OTHER

Blood samples will be taken to assess platelet function. There is no change in treatment.

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • BRIAN TOMLINSON, MD · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-02
Primary Completion
2021-04-01
Completion
2021-04-01

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04863053 on ClinicalTrials.gov